• Leading brokers name 3 ASX shares to buy today

    Broker written in white with a man drawing a yellow underline.

    With lots of ASX shares to choose from on the Australian market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. 

    Three top ASX shares that leading brokers have named as buys this week are outlined below. Let’s see why they are bullish on them.

    ARB Corporation Ltd (ASX: ARB)

    According to a note out of Morgans, its analysts have upgraded this 4×4 accessories company’s shares to a buy rating with a $22.35 price target. Morgans made the move in response to positive new vehicle sales during the month of June. This could be good news for ARB because it has a history of outperforming the market with its aftermarket sales. And while it has trimmed its earnings estimates slightly for FY 2026, it has boosted its medium-term forecasts. This partly reflects easing supply constraints for Toyota vehicles. Combined with significant share price weakness this year, Morgans thinks now could be a good time to invest. The ARB share price last traded at $18.03.

    Mesoblast Ltd (ASX: MSB)

    A note out of Bell Potter reveals that its analysts have put a buy rating and $4.45 price target on this biotechnology company’s shares. This follows the release of a fourth-quarter update which revealed 20% quarter on quarter revenue growth. Bell Potter believes its full year performance represents an outstanding result considering its Ryoncil product was launched from a standing start in April 2025 and prior to broad reimbursement availability. The broker notes that commercial adoption has been exceptionally strong and has continued to grow as barriers to adoption have fallen away. Looking ahead, the broker expects Ryoncil’s strong growth to continue. Bell Potter is also optimistic on Mesoblast’s Rexlemestrocel-L product. The Mesoblast share price was fetching $2.35 at Monday’s close.

    Sigma Healthcare Ltd (ASX: SIG)

    Analysts at Macquarie have retained their outperform rating and $3.50 price target on this pharmacy chain operator’s shares. According to the note, the broker has been looking at the consumer sector and continues to rate Sigma Healthcare as a preferred pick. Macquarie is bullish on the company due to its attractive valuation and exposure to structural tailwinds that are supporting the pharmacy industry. The Sigma Healthcare share price last traded at $2.92. 

    The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in ARB Corporation right now?

    Before you buy ARB Corporation shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and ARB Corporation wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ARB Corporation and Macquarie Group. The Motley Fool Australia has recommended ARB Corporation and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 3 ASX ETFs with strong long-term growth potential

    ETF spelt out with a rising green arrow.

    I think ASX exchange traded funds (ETFs) can be an easy way to invest in long-term growth themes.

    But which funds could have strong long-term growth potential?

    Three that could deliver on this are named below. Here’s what they offer investors:

    Betashares Global Cybersecurity ETF (ASX: HACK)

    The Betashares Global Cybersecurity ETF could be a strong option for investors looking beyond traditional technology exposure.

    Cybersecurity is no longer just an afterthought for businesses. It has become a boardroom, customer trust, regulatory, and business continuity issue.

    Companies now rely on cloud platforms, remote workers, digital payments, online customer data, artificial intelligence tools, and connected devices. Each of these creates more points that need protecting.

    This popular ASX ETF gives investors exposure to companies involved in areas such as identity security, endpoint protection, network defence, cloud security, and threat detection.

    The growth case is straightforward. As more value moves online, more money is likely to be spent keeping it safe. This could bode well for holdings such as Palo Alto Networks (NASDAQ: PANW) and Fortinet (NASDAQ: FTNT).

    Betashares Asia Technology Tigers ETF (ASX: ASIA)

    The Betashares Asia Technology Tigers ETF offers a different type of technology exposure.

    Many investors think of technology through a US lens, but Asia plays a huge role in the global digital economy.

    The region is home to major companies involved in semiconductors, hardware, ecommerce, gaming, cloud services, digital platforms, and consumer technology. This includes WeChat owner Tencent Holdings and search and robotaxi giant Baidu (NASDAQ: BIDU).

    That gives this ASX ETF exposure to both sides of the technology story. Asia helps build many of the components that power the digital world, while also serving enormous consumer markets that continue to adopt new online services.

    It is worth noting that the fund is more concentrated than a broad global ETF, so investors should expect ups and downs. But given its strong long-term growth potential, the rewards could comfortably outweigh the risks.

    Betashares S&P/ASX Australian Technology ETF (ASX: ATEC)

    Finally, the Betashares S&P/ASX Australian Technology ETF brings the growth story closer to home.

    This ASX ETF invests in Australian technology companies, giving investors exposure to a part of the local market that looks very different from banks and miners.

    Its holdings can include businesses involved in software, digital marketplaces, payments, online services, and technology-enabled platforms. This includes Xero Ltd (ASX: XRO) and WiseTech Global Ltd (ASX: WTC).

    This means that the fund gives investors a way to back local innovation without relying on one company to deliver.

    It may not be as diversified as a broad market fund, and smaller technology shares can be sensitive to interest rates and investor sentiment. But if Australia continues producing globally competitive digital businesses, this fund could have plenty of long-term growth potential.

    The post 3 ASX ETFs with strong long-term growth potential appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Betashares Capital – Asia Technology Tigers Etf right now?

    Before you buy Betashares Capital – Asia Technology Tigers Etf shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Betashares Capital – Asia Technology Tigers Etf wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Betashares Capital – Asia Technology Tigers Etf, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Baidu, BetaShares Global Cybersecurity ETF, Fortinet, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Palo Alto Networks. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Buy, hold, sell: L1 Long Short Fund, REA, Wesfarmers shares

    A graphic showing three hands holding red paddles with the word BID, indicating a bidding war for an ASX share company

    S&P/ASX 200 Index (ASX: XJO) shares edged 2.77% higher and generated total returns, including dividends, of 7% in FY26.   

    Among the 11 market sectors, materials was the best performer of the year, rising 47% and producing a total return of 52%.

    The worst-performing sector was healthcare, which fell 37% and produced a total negative return of 36%.

    On The Bull this week, Andrew Wielandt from DP Wealth Advisory lets us in on some stock tips for the new financial year.

    L1 Long Short Fund (ASX: LSF)

    Wielandt has a buy rating on this ASX listed investment company (LIC), which he holds in his personal self-managed super fund.

    He explains:

    LSF provides exposure to long and short strategies on a global scale, meaning it takes either a positive or negative view on each position in the portfolio.

    The strategy holds between 50 and 100 companies, with 30 per cent or less held offshore.

    The fund has delivered returns of 20.2 per cent per annum since its inception in 2014.

    LSF has risen from $2.97 on July 10, 2025 to trade at $4.66 on July 9, 2026.

    The fund has a strong track record of delivering results and I believe the outlook is bright.

    Wesfarmers Ltd (ASX: WES) 

    The Wesfarmers share price rose 7% to close out FY26 at $90.40 per share.

    Wielandt has a hold rating on the market’s largest ASX 200 consumer discretionary share.

    He said:

    WES is one of Australia’s largest diversified industrial companies, spanning retail, chemicals, fertilisers, industrials and health.

    The retail division, including hardware giant Bunnings, Kmart Group and Officeworks, continues to perform well despite a slowing domestic economy.

    Investment in the Priceline pharmacy chain provides upside potential.

    WES generates a strong return on shareholders funds, but the stock is trading near a 12-month broker consensus target price, so we retain a hold recommendation.

    REA Group Ltd (ASX: REA)

    The REA share price tumbled 42% to finish FY26 at $139.19.

    Wielandt has a sell rating on this ASX 200 communications share. 

    He explained: 

    REA is the dominant online property platform in Australia. But competitor Domain Holdings Australia, acquired by US listed company CoStar Group, is expected to provide fierce competition.

    Federal Budget changes to capital gains tax and negative gearing leaves property far less appealing to investors.

    The Australian property market is slowing, which could impact REA listing volumes moving forward.

    Auction clearance rates have been falling in Sydney and Melbourne. Other stocks appeal more at this stage of the cycle.

    The post Buy, hold, sell: L1 Long Short Fund, REA, Wesfarmers shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Wesfarmers right now?

    Before you buy Wesfarmers shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CoStar Group and Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.